Recruiting Prostate Cancer Studies in Towson
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
In this Phase 2 study, mCRPC patients with PSMA positive scans who progressed on prior ARTA and up to 2 lines of taxanes, and are naïve to lutetium Lu 177 vipivotide tetraxetan, will be enrolled. The ...
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application
Phase 1: The objective of the Phase 1 part of the clinical trial is to verify safety and tolerability (dose-limiting toxicity \[DLT\], maximum tolerated dose \[MTD\]) of a single 3.7 Giga-Becquerel (G...
About Prostate Cancer Clinical Trials in Towson
Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.
There are currently 2 prostate cancer clinical trials recruiting participants in Towson, MARYLAND. These studies are seeking a combined 167 participants. Research is being sponsored by OncoC4, Inc., FutureChem. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prostate Cancer Clinical Trials in Towson — FAQ
Are there prostate cancer clinical trials in Towson?
Yes, there are 2 prostate cancer clinical trials currently recruiting in Towson, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Towson?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Towson research site will contact you about next steps.
Are clinical trials in Towson free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Towson studies also compensate for your time and travel.
What prostate cancer treatments are being tested?
The 2 active trials in Towson are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.
Data updated March 2, 2026 from ClinicalTrials.gov